Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy

Hemodialysis is a life-sustaining therapy for millions of people worldwide. However, despite considerable technical and scientific improvements, results are still not fully satisfactory in terms of morbidity and mortality. The membrane contained in the hemodialyzer is undoubtedly the main determinan...

Full description

Bibliographic Details
Main Authors: Mario Bonomini, Luca Piscitani, Lorenzo Di Liberato, Vittorio Sirolli
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/4/844
_version_ 1797436731359756288
author Mario Bonomini
Luca Piscitani
Lorenzo Di Liberato
Vittorio Sirolli
author_facet Mario Bonomini
Luca Piscitani
Lorenzo Di Liberato
Vittorio Sirolli
author_sort Mario Bonomini
collection DOAJ
description Hemodialysis is a life-sustaining therapy for millions of people worldwide. However, despite considerable technical and scientific improvements, results are still not fully satisfactory in terms of morbidity and mortality. The membrane contained in the hemodialyzer is undoubtedly the main determinant of the success and quality of hemodialysis therapy. Membrane properties influence solute removal and the interactions with blood components that define the membrane’s biocompatibility. Bioincompatibility is considered a potential contributor to several uremic complications. Thus, the development of more biocompatible polymers used as hemodialyzer membrane is of utmost importance for improving results and clinical patient outcomes. Many different surface-modified membranes for hemodialysis have been manufactured over recent years by varying approaches in the attempt to minimize blood incompatibility. Their main characteristics and clinical results in hemodialysis patients were reviewed in the present article.
first_indexed 2024-03-09T11:06:47Z
format Article
id doaj.art-1c1d7be5e0d341b1b66089e22c0a87b6
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T11:06:47Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1c1d7be5e0d341b1b66089e22c0a87b62023-12-01T00:54:12ZengMDPI AGBiomedicines2227-90592022-04-0110484410.3390/biomedicines10040844Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis TherapyMario Bonomini0Luca Piscitani1Lorenzo Di Liberato2Vittorio Sirolli3Nephrology and Dialysis Unit, Department of Medicine, G. d’Annunzio University, Chieti-Pescara, SS. Annunziata Hospital, Via dei Vestini, 66013 Chieti, ItalyNephrology and Dialysis Unit, Department of Medicine, San Salvatore Hospital, Via Vetoio, 67100 L’Aquila, ItalyNephrology and Dialysis Unit, Department of Medicine, G. d’Annunzio University, Chieti-Pescara, SS. Annunziata Hospital, Via dei Vestini, 66013 Chieti, ItalyNephrology and Dialysis Unit, Department of Medicine, G. d’Annunzio University, Chieti-Pescara, SS. Annunziata Hospital, Via dei Vestini, 66013 Chieti, ItalyHemodialysis is a life-sustaining therapy for millions of people worldwide. However, despite considerable technical and scientific improvements, results are still not fully satisfactory in terms of morbidity and mortality. The membrane contained in the hemodialyzer is undoubtedly the main determinant of the success and quality of hemodialysis therapy. Membrane properties influence solute removal and the interactions with blood components that define the membrane’s biocompatibility. Bioincompatibility is considered a potential contributor to several uremic complications. Thus, the development of more biocompatible polymers used as hemodialyzer membrane is of utmost importance for improving results and clinical patient outcomes. Many different surface-modified membranes for hemodialysis have been manufactured over recent years by varying approaches in the attempt to minimize blood incompatibility. Their main characteristics and clinical results in hemodialysis patients were reviewed in the present article.https://www.mdpi.com/2227-9059/10/4/844biocompatibilityhemodialysismembranebiomaterialprotein adsorptioncoagulation
spellingShingle Mario Bonomini
Luca Piscitani
Lorenzo Di Liberato
Vittorio Sirolli
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
Biomedicines
biocompatibility
hemodialysis
membrane
biomaterial
protein adsorption
coagulation
title Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
title_full Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
title_fullStr Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
title_full_unstemmed Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
title_short Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy
title_sort biocompatibility of surface modified membranes for chronic hemodialysis therapy
topic biocompatibility
hemodialysis
membrane
biomaterial
protein adsorption
coagulation
url https://www.mdpi.com/2227-9059/10/4/844
work_keys_str_mv AT mariobonomini biocompatibilityofsurfacemodifiedmembranesforchronichemodialysistherapy
AT lucapiscitani biocompatibilityofsurfacemodifiedmembranesforchronichemodialysistherapy
AT lorenzodiliberato biocompatibilityofsurfacemodifiedmembranesforchronichemodialysistherapy
AT vittoriosirolli biocompatibilityofsurfacemodifiedmembranesforchronichemodialysistherapy